603983 丸美生物
交易中 02-02 13:07:14
资讯
新帖
简况
山东“夫妻店”冲刺港交所，卖洗护品9个月收入超18亿，林清轩创始人也突击入股
时代财经 · 01-17
山东“夫妻店”冲刺港交所，卖洗护品9个月收入超18亿，林清轩创始人也突击入股
“急闯”港股，丸美生物突围还是解困？
中国基金报 · 01-13
“急闯”港股，丸美生物突围还是解困？
每周股票复盘：丸美生物（603983）完成取消监事会工商变更
证券之星 · 01-11
每周股票复盘：丸美生物（603983）完成取消监事会工商变更
丸美生物（603983）披露关于完成工商变更登记的公告，1月5日股价上涨1.36%
证券之星 · 01-05
丸美生物（603983）披露关于完成工商变更登记的公告，1月5日股价上涨1.36%
每周股票复盘：丸美生物（603983）募投项目延期获股东高票通过
证券之星 · 01-02
每周股票复盘：丸美生物（603983）募投项目延期获股东高票通过
丸美生物（603983）披露部分募集资金投资项目延期公告，12月30日股价上涨2.6%
证券之星 · 2025-12-30
丸美生物（603983）披露部分募集资金投资项目延期公告，12月30日股价上涨2.6%
每周股票复盘：丸美生物（603983）募投项目延期至2027年12月
证券之星 · 2025-12-28
每周股票复盘：丸美生物（603983）募投项目延期至2027年12月
丸美生物（603983）披露化妆品智能制造工厂建设项目延期公告，12月25日股价上涨0.52%
证券之星 · 2025-12-25
丸美生物（603983）披露化妆品智能制造工厂建设项目延期公告，12月25日股价上涨0.52%
丸美生物赴港IPO：销售及营销费用占收入过半
澎湃新闻 · 2025-12-23
丸美生物赴港IPO：销售及营销费用占收入过半
丸美生物A+H：虚增收入挪用募资被警示、募投项目频频延期分红却不手软 营销开支是研发投入的22倍
新浪证券 · 2025-12-23
丸美生物A+H：虚增收入挪用募资被警示、募投项目频频延期分红却不手软 营销开支是研发投入的22倍
整改后13天即闯港股，8亿分红落袋实控人，丸美生物急什么？
风口财经 · 2025-12-22
整改后13天即闯港股，8亿分红落袋实控人，丸美生物急什么？
科技赋能双品牌矩阵，丸美生物加速构建美妆行业竞争护城河
智通财经 · 2025-12-22
科技赋能双品牌矩阵，丸美生物加速构建美妆行业竞争护城河
港股IPO监管升级，丸美生物能否越过“财务问题”门槛成功上市？
市场资讯 · 2025-12-15
港股IPO监管升级，丸美生物能否越过“财务问题”门槛成功上市？
新股消息 | 丸美生物(603983.SH)递表港交所
智通财经 · 2025-12-12
新股消息 | 丸美生物(603983.SH)递表港交所
屈臣氏拟明年于香港伦敦双重上市
山东商报 · 2025-12-02
屈臣氏拟明年于香港伦敦双重上市
丸美生物（603983）披露拟首次公开发行H股并在港交所上市，12月1日股价上涨0.11%
证券之星 · 2025-12-01
丸美生物（603983）披露拟首次公开发行H股并在港交所上市，12月1日股价上涨0.11%
11月25日丸美生物涨5.08%，富国消费主题混合A基金重仓该股
证券之星 · 2025-11-25
11月25日丸美生物涨5.08%，富国消费主题混合A基金重仓该股
丸美生物涨5.08%，开源证券三周前给出“买入”评级
证券之星 · 2025-11-25
丸美生物涨5.08%，开源证券三周前给出“买入”评级
账上15亿，分红超10亿，丸美生物为何仍要赴港融资？
市场资讯 · 2025-11-17
账上15亿，分红超10亿，丸美生物为何仍要赴港融资？
每周股票复盘：XD丸美生（603983）丸美生物拟发行H股并延期募投项目
证券之星 · 2025-11-16
每周股票复盘：XD丸美生（603983）丸美生物拟发行H股并延期募投项目
加载更多
公司概况
公司名称：
广东丸美生物技术股份有限公司
所属行业：
化学原料和化学制品制造业
上市日期：
2019-07-25
主营业务：
广东丸美生物技术股份有限公司的主营业务是化妆品的研发、设计、生产、销售及服务。公司的主要产品是眼部类、护肤类、洁肤类、美容及其他类。公司关键技术“重组胶原蛋白高效嵌合表达及抗衰研究”荣膺IFSCC“2025中国化妆品技术创新奖”。
发行价格：
20.54
{"stockData":{"symbol":"603983","market":"SH","secType":"STK","nameCN":"丸美生物","latestPrice":31.67,"timestamp":1770008834000,"preClose":31.52,"halted":0,"volume":1498900,"delay":0,"changeRate":0.0048,"floatShares":401000000,"shares":401000000,"eps":0.8647,"marketStatus":"交易中","change":0.15,"latestTime":"02-02 13:07:14","open":31.42,"high":32.05,"low":31.21,"amount":47553100,"amplitude":0.0266,"askPrice":31.7,"askSize":6,"bidPrice":31.67,"bidSize":39,"shortable":0,"etf":0,"ttmEps":0.8647,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1770015600000},"marketStatusCode":2,"adr":0,"adjPreClose":31.52,"symbolType":"stock","openAndCloseTimeList":[[1769995800000,1770003000000],[1770008400000,1770015600000]],"highLimit":34.67,"lowLimit":28.37,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":401000000,"isCdr":false,"pbRate":3.8,"roa":"--","peRate":36.625419,"roe":"7.17%","epsLYR":0.85,"committee":-0.291139,"marketValue":12700000000,"turnoverRate":0.0037,"status":0,"floatMarketCap":12700000000},"requestUrl":"/m/hq/s/603983","defaultTab":"news","newsList":[{"id":"2604452209","title":"山东“夫妻店”冲刺港交所，卖洗护品9个月收入超18亿，林清轩创始人也突击入股","url":"https://stock-news.laohu8.com/highlight/detail?id=2604452209","media":"时代财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604452209?lang=zh_cn&edition=full","pubTime":"2026-01-17 13:41","pubTimestamp":1768628460,"startTime":"0","endTime":"0","summary":"孙颖莎代言的半亩花田突袭港股IPO。1月16日晚间，本土美妆个护品牌半亩花田主体公司——山东花物堂化妆品股份有限公司（后称：“半亩花田”）向港交所递交上市申请书，中信证券为其独家保荐 ...","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20260117/c674097777.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["BK0028","BK0229","603983","BK0267","BK0098","BK0268","001222","BK0012","BK0254","BK0188","BK0087","BK0094","601928"],"gpt_icon":0},{"id":"2603631341","title":"“急闯”港股，丸美生物突围还是解困？","url":"https://stock-news.laohu8.com/highlight/detail?id=2603631341","media":"中国基金报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603631341?lang=zh_cn&edition=full","pubTime":"2026-01-13 21:34","pubTimestamp":1768311240,"startTime":"0","endTime":"0","summary":"就在2025年10月底，丸美生物因财务核算不规范等问题被监管部门责令改正。在业内人士看来，国货美妆行业竞争激烈也是丸美生物赴港上市的原因之一。同时，丸美生物的机构股东也在减少。“烧钱换增长”难以为继在营收方面，丸美生物保持增长势头，2024年营收为29.70亿元，2025年仅前三季度营收已达到24.50亿元。与营收的快速增长相比，丸美生物的净利润增长却明显放缓。丸美生物2025年前三季度的营销费用为14.15亿元，费用率攀升至57.7%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":null,"url":"http://mp.weixin.qq.com/s?__biz=MzA5MDEzNjQwMA==&mid=2656340773&idx=2&sn=75c29085842ba7551921b2d4a690aa6b&chksm=8a7c0c60810771ee37c168c2b18e493d7ee73a993766c9ace3ac04c9716ef4ed2a92cf356aec&scene=0#rd","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzA5MDEzNjQwMA==&mid=2656340773&idx=2&sn=75c29085842ba7551921b2d4a690aa6b&chksm=8a7c0c60810771ee37c168c2b18e493d7ee73a993766c9ace3ac04c9716ef4ed2a92cf356aec&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["603983","BK0229"],"gpt_icon":0},{"id":"2602536978","title":"每周股票复盘：丸美生物（603983）完成取消监事会工商变更","url":"https://stock-news.laohu8.com/highlight/detail?id=2602536978","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602536978?lang=zh_cn&edition=full","pubTime":"2026-01-11 04:03","pubTimestamp":1768075389,"startTime":"0","endTime":"0","summary":"截至2026年1月9日收盘，丸美生物报收于34.46元，较上周的33.15元上涨3.95%。本周，丸美生物1月9日盘中最高价报34.67元。本周关注点公司公告汇总：丸美生物已完成取消监事会及修订《公司章程》的工商变更登记。公司公告汇总广东丸美生物技术股份有限公司于2025年10月29日召开第五届董事会第九次会议，于2025年11月28日召开2025年第二次临时股东大会，审议通过了关于取消监事会并修订《公司章程》及修订、新增公司部分治理制度的议案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011100001314.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603983","BK0229"],"gpt_icon":0},{"id":"2601883869","title":"丸美生物（603983）披露关于完成工商变更登记的公告，1月5日股价上涨1.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601883869","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601883869?lang=zh_cn&edition=full","pubTime":"2026-01-05 23:17","pubTimestamp":1767626233,"startTime":"0","endTime":"0","summary":"截至2026年1月5日收盘，丸美生物报收于33.6元，较前一交易日上涨1.36%，最新总市值为134.74亿元。公司近日发布公告称，广东丸美生物技术股份有限公司于2025年10月29日召开第五届董事会第九次会议，于2025年11月28日召开2025年第二次临时股东大会，审议通过了关于取消监事会并修订《公司章程》及修订、新增公司部分治理制度的议案。近日，公司已完成上述事项相关的工商变更登记及《公司章程》备案手续，营业执照登记信息不变。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500041080.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603983","BK0229"],"gpt_icon":0},{"id":"2600039690","title":"每周股票复盘：丸美生物（603983）募投项目延期获股东高票通过","url":"https://stock-news.laohu8.com/highlight/detail?id=2600039690","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600039690?lang=zh_cn&edition=full","pubTime":"2026-01-02 04:01","pubTimestamp":1767297672,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘，丸美生物报收于33.09元，较上周的33.65元下跌1.66%。本周，丸美生物12月22日盘中最高价报33.85元。丸美生物当前最新总市值132.93亿元，在化妆品板块市值排名4/14，在两市A股市值排名1463/5181。会议审议通过《关于部分募集资金投资项目延期的议案》。出席会议的股东及代理人共161人，代表有表决权股份总数的83.5599%。表决结果显示，议案获得99.9432%的同意票，反对占0.0455%，弃权占0.0113%。中小股东中98.2844%投出同意票。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010200001182.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","603983"],"gpt_icon":0},{"id":"2595755718","title":"丸美生物（603983）披露部分募集资金投资项目延期公告，12月30日股价上涨2.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595755718","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595755718?lang=zh_cn&edition=full","pubTime":"2025-12-30 22:31","pubTimestamp":1767105073,"startTime":"0","endTime":"0","summary":"截至2025年12月30日收盘，丸美生物报收于33.18元，较前一交易日上涨2.6%，最新总市值为133.05亿元。近日，广东信达律师事务所发布了关于广东丸美生物技术股份有限公司2025年第三次临时股东会的法律意见书。公告显示，丸美生物于2025年12月30日召开2025年第三次临时股东会，会议审议通过《关于部分募集资金投资项目延期的议案》。现场及网络投票合计出席股东161人，代表有表决权股份总数83.5599%。表决结果显示，议案获得99.9432%的同意票，反对占0.0455%，弃权占0.0113%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123000044413.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603983","BK0229"],"gpt_icon":0},{"id":"2594247950","title":"每周股票复盘：丸美生物（603983）募投项目延期至2027年12月","url":"https://stock-news.laohu8.com/highlight/detail?id=2594247950","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594247950?lang=zh_cn&edition=full","pubTime":"2025-12-28 05:06","pubTimestamp":1766869574,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘，丸美生物报收于33.09元，较上周的33.65元下跌1.66%。本周，丸美生物12月22日盘中最高价报33.85元。丸美生物当前最新总市值132.69亿元，在化妆品板块市值排名4/14，在两市A股市值排名1472/5178。本周关注点公司公告汇总：化妆品智能制造工厂建设项目延期至2027年12月公司公告汇总广东丸美生物技术股份有限公司拟将“化妆品智能制造工厂建设项目”的预定可使用状态日期由2025年12月延期至2027年12月。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122800001362.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603983","BK0229"],"gpt_icon":0},{"id":"2594237445","title":"丸美生物（603983）披露化妆品智能制造工厂建设项目延期公告，12月25日股价上涨0.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2594237445","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594237445?lang=zh_cn&edition=full","pubTime":"2025-12-25 22:28","pubTimestamp":1766672904,"startTime":"0","endTime":"0","summary":"截至2025年12月25日收盘，丸美生物报收于32.79元，较前一交易日上涨0.52%，最新总市值为131.49亿元。该股当日开盘32.65元，最高32.95元，最低32.36元，成交额达6477.99万元，换手率为0.5%。近日，丸美生物发布公告称，公司拟将“化妆品智能制造工厂建设项目”的预定可使用状态日期由2025年12月延期至2027年12月。该项目募集资金投资总额为25,026.35万元，截至2025年6月30日已投入24,765.27万元。项目实施主体、投资总额及用途不变，不影响公司正常经营。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122500036137.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","603983"],"gpt_icon":0},{"id":"2593473880","title":"丸美生物赴港IPO：销售及营销费用占收入过半","url":"https://stock-news.laohu8.com/highlight/detail?id=2593473880","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593473880?lang=zh_cn&edition=full","pubTime":"2025-12-23 17:41","pubTimestamp":1766482913,"startTime":"0","endTime":"0","summary":"从业绩表现来看，近年来丸美生物营收及利润呈增长态势。销售及营销费用占收入过半根据申请文件，丸美生物通过线上线下渠道销售产品。从数据来看，丸美生物的销售费用占营收过半。数据显示，2022-2024年及2025年前三季度，丸美生物的销售及营销费用分别为8.46亿元、11.99亿元、16.35亿元及14.15亿元，占各期总收入比例依次为48.8%、53.9%、55.1%及57.7%。丸美生物于2025年11月29日披露整改报告，称已修正财务数据并完善相关制度流程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"fenghuang_stock","url":"https://finance.ifeng.com/c/8pK2uZqqXBp","rn_cache_url":null,"customStyle":"","selectors":"article, body","filters":"","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.ifeng.com/c/8pK2uZqqXBp","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fenghuang_stock","symbols":["BK0229","603983"],"gpt_icon":0},{"id":"2593295495","title":"丸美生物A+H：虚增收入挪用募资被警示、募投项目频频延期分红却不手软 营销开支是研发投入的22倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2593295495","media":"新浪证券","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593295495?lang=zh_cn&edition=full","pubTime":"2025-12-23 17:36","pubTimestamp":1766482560,"startTime":"0","endTime":"0","summary":" 12月12日晚，丸美生物发布公告，公司向港交所递交招股书，启动“A+H”上市进程。作为2019年登陆A股的“眼霜第一股”，丸美生物此次南下，计划将募集资金用于加强线上线下渠道、品牌营销、研发投入及一般运营。2021年8月28日，丸美生物公告项目延期至2023年7月25日，2023年8月26日公告项目将再次延期至2026年7月，明年该项目是否会继续延期尚未可知。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/observe/2025-12-23/doc-inhcuunm5323272.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["603983","BK0229"],"gpt_icon":0},{"id":"2593248213","title":"整改后13天即闯港股，8亿分红落袋实控人，丸美生物急什么？","url":"https://stock-news.laohu8.com/highlight/detail?id=2593248213","media":"风口财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593248213?lang=zh_cn&edition=full","pubTime":"2025-12-22 20:13","pubTimestamp":1766405580,"startTime":"0","endTime":"0","summary":"近日，国内化妆品企业丸美股份的运营主体——广东丸美生物技术股份有限公司（以下简称“丸美生物”）发布公告，宣布已正式向香港联合交易所递交H股上市申请。值得关注的是，此次递表距离该 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/20251222/c673411510.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["603983","BK0229"],"gpt_icon":0},{"id":"2593171475","title":"科技赋能双品牌矩阵，丸美生物加速构建美妆行业竞争护城河","url":"https://stock-news.laohu8.com/highlight/detail?id=2593171475","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593171475?lang=zh_cn&edition=full","pubTime":"2025-12-22 08:58","pubTimestamp":1766365101,"startTime":"0","endTime":"0","summary":"近日，以“生物科技美妆”为核心的丸美生物正式向港交所递交上市申请。以2024年零售额计，公司是重组胶原蛋白护肤品细分领域的中国第三大美妆企业，构筑了坚实的竞争护城河。总体来看，在消费者愈发关注产品成分与科技含量的当下，丸美生物凭借其在生物科技领域的持续投入、清晰的品牌布局以及健康的盈利表现，已在国货美妆的科技化转型中占据重要位置。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1384193.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["603983","BK0229"],"gpt_icon":0},{"id":"2591695848","title":"港股IPO监管升级，丸美生物能否越过“财务问题”门槛成功上市？","url":"https://stock-news.laohu8.com/highlight/detail?id=2591695848","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591695848?lang=zh_cn&edition=full","pubTime":"2025-12-15 00:00","pubTimestamp":1765728000,"startTime":"0","endTime":"0","summary":" 近日，香港证监会与港交所罕见地联名致函所有保荐机构，直指当前港股IPO申请材料质量下滑、不合规行为增多。今年截至11月底，港股IPO募资额已飙至2594亿港元，同比激增2.28倍，创四年新高。 如今转向港股，在监管对材料质量和信息披露要求显著提升的背景下，丸美生物能否彻底厘清历史财务问题，跨越这道关键的合规门槛，成为其上市成败的关键一环。值得留意的是，2023年及2024年，丸美生物分红比例均超过80%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggipo/2025-12-15/doc-inhavwnp4255565.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0229","603983"],"gpt_icon":0},{"id":"2590542059","title":"新股消息 | 丸美生物(603983.SH)递表港交所","url":"https://stock-news.laohu8.com/highlight/detail?id=2590542059","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590542059?lang=zh_cn&edition=full","pubTime":"2025-12-12 06:19","pubTimestamp":1765491549,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，据港交所12月11日披露，广东丸美生物技术股份有限公司(603983.SH)向港交所主板递交上市申请，高盛、中信证券为其联席保荐人。招股书显示，丸美生物是专注于为消费者提供抗衰解决方案的中国领先美妆企业。公司以合成生物学技术驱动，深耕抗衰护肤品行业二十余年，不断通过专注于研发及以重组胶原蛋白为代表的核心技术突破，将前沿科技创新应用到具有抗皱、紧致和修护等功效的护肤产品中。基于弗若斯特沙利文报告，以2024年零售额计，丸美生物是重组胶原蛋白护肤品细分领域的中国第三大美妆企业。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1380651.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0229","HEXmain","603983"],"gpt_icon":0},{"id":"2588009817","title":"屈臣氏拟明年于香港伦敦双重上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2588009817","media":"山东商报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588009817?lang=zh_cn&edition=full","pubTime":"2025-12-02 09:43","pubTimestamp":1764639780,"startTime":"0","endTime":"0","summary":"商报消息 日前，据《华尔街日报》等媒体援引知情人士消息，李嘉诚旗下长江和记实业有限公司（00001.HK，下称“长和”）旗下的屈臣氏集团正计划在中国香港、英国伦敦双重上市。若此次上市进 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20251202/c672887543.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["LU1146622755.USD","LU1997245177.USD","603605","LU2460026573.USD","BK0217","BK0229","003010","IE0005HP3H50.USD","LU0593848301.USD","LU1820825898.SGD","603983","LU1997245094.SGD"],"gpt_icon":0},{"id":"2588093725","title":"丸美生物（603983）披露拟首次公开发行H股并在港交所上市，12月1日股价上涨0.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588093725","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588093725?lang=zh_cn&edition=full","pubTime":"2025-12-01 17:55","pubTimestamp":1764582933,"startTime":"0","endTime":"0","summary":"根据近日发布的公告，广东丸美生物技术股份有限公司于2025年11月28日召开2025年第二次临时股东大会，会议审议通过了关于公司首次公开发行H股股票并在香港联合交易所上市的相关议案，包括发行方案、募集资金使用计划、转为境外募集股份有限公司、授权董事会办理上市事宜等。同时，会议还审议通过了取消监事会并修订公司章程、选举第五届董事会独立董事、制定H股上市后适用的公司章程（草案）及多项内部治理制度修订议案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120100023701.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","HEXmain","603983"],"gpt_icon":0},{"id":"2586040442","title":"11月25日丸美生物涨5.08%，富国消费主题混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2586040442","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586040442?lang=zh_cn&edition=full","pubTime":"2025-11-25 15:33","pubTimestamp":1764055984,"startTime":"0","endTime":"0","summary":"证券之星消息，11月25日丸美生物涨5.08%创60日新低，收盘报34.57元，换手率1.83%，成交量7.33万手，成交额2.51亿元。根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共7家，其中持有数量最多的公募基金为富国基金的富国消费主题混合A。富国消费主题混合A目前规模为31.65亿元，最新净值2.22，较上一交易日下跌0.76%，近一年上涨2.92%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112500017324.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603983","BK0229"],"gpt_icon":0},{"id":"2586805447","title":"丸美生物涨5.08%，开源证券三周前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2586805447","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586805447?lang=zh_cn&edition=full","pubTime":"2025-11-25 15:32","pubTimestamp":1764055975,"startTime":"0","endTime":"0","summary":"今日丸美生物涨5.08%，收盘报34.57元。2025年11月2日，开源证券研究员黄泽鹏,李昕恬发布了对丸美生物的研报《公司信息更新报告：2025Q3业绩亮眼，多赛道布局有望驱动业绩增长》，该研报对丸美生物给出“买入”评级。研报中预计公司2025-2027年归母净利润为4.00/5.23/6.67亿元，对应EPS为1.00/1.30/1.66元，当前股价对应PE为34.6/26.5/20.8倍，维持“买入”评级。此外，东吴证券研究员吴劲草,郗越，华源证券研究员丁一近期也对该股发布了研报，同样给出“买入”评级。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112500017319.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603983","161027"],"gpt_icon":0},{"id":"2584320614","title":"账上15亿，分红超10亿，丸美生物为何仍要赴港融资？","url":"https://stock-news.laohu8.com/highlight/detail?id=2584320614","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584320614?lang=zh_cn&edition=full","pubTime":"2025-11-17 13:41","pubTimestamp":1763358060,"startTime":"0","endTime":"0","summary":" 丸美生物正计划在资本市场上完成一次新的“图谋”。 在登陆A股六年后，丸美生物于11月12日正式宣布拟发行H股股票，意欲搭建“A+H”双资本平台。该项目历经多次变更，并在2023年与2024年两度延期后，于宣布赴港上市的同日，再次决定延期两年。截至三季度末，丸美生物账上货币资金高达15.92亿元，交易性金融资产达4.13亿元，且经营活动现金流同比激增132.19%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hyyj/2025-11-17/doc-infxsxya6444458.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["603983","BK0229"],"gpt_icon":0},{"id":"2583654856","title":"每周股票复盘：XD丸美生（603983）丸美生物拟发行H股并延期募投项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2583654856","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583654856?lang=zh_cn&edition=full","pubTime":"2025-11-16 04:18","pubTimestamp":1763237891,"startTime":"0","endTime":"0","summary":"截至2025年11月14日收盘，XD丸美生报收于33.45元，较上周的33.56元下跌0.33%。本周，XD丸美生11月14日盘中最高价报34.77元。XD丸美生当前最新总市值134.13亿元，在化妆品板块市值排名4/14，在两市A股市值排名1433/5165。本周关注点公司公告汇总：丸美生物拟发行H股并在港交所主板上市，相关议案已获董事会审议通过。监事会及保荐人中信证券对该延期事项无异议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111600001181.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603983","BK0229"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1770008871070,"stockEarnings":[{"period":"1week","weight":-0.0636},{"period":"1month","weight":-0.0492},{"period":"3month","weight":-0.0804},{"period":"6month","weight":-0.1793},{"period":"1year","weight":-0.0269},{"period":"ytd","weight":-0.0492}],"compareEarnings":[{"period":"1week","weight":-0.0044},{"period":"1month","weight":0.0376},{"period":"3month","weight":0.0413},{"period":"6month","weight":0.1567},{"period":"1year","weight":0.2668},{"period":"ytd","weight":0.0376}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"广东丸美生物技术股份有限公司","boardCode":"AI0026","boardName":"化学原料和化学制品制造业","stockholders":"18910人(较上一季度增加8.86%)","perCapita":"21205股","listingDate":"2019-07-25","address":"广东省广州市黄埔区高新技术产业开发区科学城伴河路92号2号楼","registeredCapital":"40100万元","survey":" 广东丸美生物技术股份有限公司的主营业务是化妆品的研发、设计、生产、销售及服务。公司的主要产品是眼部类、护肤类、洁肤类、美容及其他类。公司关键技术“重组胶原蛋白高效嵌合表达及抗衰研究”荣膺IFSCC“2025中国化妆品技术创新奖”。","listedPrice":20.54},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"丸美生物(603983)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供丸美生物(603983)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"丸美生物,603983,丸美生物股票,丸美生物股票老虎,丸美生物股票老虎国际,丸美生物行情,丸美生物股票行情,丸美生物股价,丸美生物股市,丸美生物股票价格,丸美生物股票交易,丸美生物股票购买,丸美生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"丸美生物(603983)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供丸美生物(603983)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}